Sepsis & infection

Point-of-care presepsin and procalcitonin to rule out sepsis in patients with infectious symptoms

J Crit CarePublished Diagnostic accuracy study

Authors' conclusion

Use of presepsin yielded high negative predictive value for sepsis, especially when used in combination with PCT.

Study context

Population
Adult Emergency Department (ED) patients with acute infectious symptoms (antibiotics ordered, infectious source on imaging or lab testing, or SIRS)41 with sepsis
Participants
149 patients
Comparison
Point-of-care presepsin, procalcitonin (PCT) and their combination for ruling out sepsis
Outcome
Diagnosis of sepsis
Methodological detailssingle site, prospective, pilot observational cohort, clinical team blinded to biomarker results
  • Single site
  • Prospective
  • Pilot observational cohort
  • Clinical team blinded to biomarker results

Performance

As reported in the abstract

Sepsis by biomarker risk category; NPV for sepsis
Test or modelValueSepsis in moderate- or high-riskNPVSepsis without low-risk for both
Presepsin5.1%35.5% (39/110)94.9% (95% CI of 88.0%, 100%)
PCT9.2%60.4% (29/48)90.8% (95% CI of 85.1%, 96.5%)
Combination0%100% (95% CI of 90.3%, 100%)34.5% (38/110)

Value

Presepsin5.1%
PCT9.2%
Combination0%

Sepsis in moderate- or high-risk

Presepsin35.5% (39/110)
PCT60.4% (29/48)
Combination— not stated in the abstract

NPV

Presepsin94.9% (95% CI of 88.0%, 100%)
PCT90.8% (95% CI of 85.1%, 96.5%)
Combination100% (95% CI of 90.3%, 100%)

Sepsis without low-risk for both

Presepsin— not stated in the abstract
PCT— not stated in the abstract
Combination34.5% (38/110)
  • Presepsin low-risk vs Presepsin moderate- or high-risk: P < 0.0001 — chi-square
  • PCT low-risk vs PCT moderate- or high-risk: P < 0.0001 — chi-square
  • Both low-risk vs Not low-risk for both: P < 0.0001 — chi-square

Original publication

Point-of-care presepsin and procalcitonin to rule out sepsis in patients with infectious symptoms. J Crit Care. Published 22 May 2026. doi:10.1016/j.jcrc.2026.155616

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.